BETHESDA, Md., April 29, 2025 /PRNewswire/ -- Precision for Medicine, a global leader in biomarker-driven clinical research and development, today announced the appointment of Matt Grow as Chief ...

Doha, Qatar: The Second Forum of Naufar, focusing on the “Precision Medicine Approach in Treating Substance Use Disorders,” concluded yesterday. The Minister of Public Health H E Mansour bin ...

Synovial cell studies and PCAPs offer potential for better patient stratification, but challenges in precision medicine persist. Achieving true precision medicine in RA is a complex goal ...

On Tuesday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported first-quarter adjusted earnings per share of $8.22, down 14% year-over-year, missing the consensus of $8.82. The company reported ...

Investment includes $1.5 billion in capital expenditures to expand manufacturing and $500 million dedicated to R&D focused on ...

"We are excited to be increasingly seen as the leading non-oncology data partner of choice for precision medicine innovation," said Reg Seeto, CEO of Scipher Medicine. "InnoSIGN is a perfect ...

"We are excited to be increasingly seen as the leading non-oncology data partner of choice for precision medicine innovation," said Reg Seeto, CEO of Scipher Medicine. "InnoSIGN is a perfect example ...

Scipher Medicine is driving the probability of success at each stage of drug development from discovery to commercialization by leveraging AI with network biology, and proprietary data, through ...

Cheng Xin / Getty Images Major U.S. stock indexes were higher ... products used in artificial intelligence (AI) infrastructure. Regeneron Pharmaceuticals (REGN) shares sank when the biopharma ...

Precision medicine, also known as personalised medicine, is transforming healthcare by providing tailored treatments to patients suffering from life-threatening conditions. We are all unique ...